Sronyx Kit
Product Images NDC 51862-545

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sronyx (NDC 51862-545). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sronyx 01)

Chemical structure diagram showing the molecular structures of Levonorgestrel and Ethinyl Estradiol, the active ingredients in the product SRONYX. The two steroidal structures are depicted side-by-side with labeled functional groups.*

FDA Label Image

Figure 1 (Sronyx 02)

Two line graphs showing mean serum concentrations of Levonorgestrel and Ethinyl Estradiol over time (in hours). The first graph displays mean Levonorgestrel concentrations (pg/mL) after a single dose and on day 21 of cycles 1 and 3, with data points up to 25 hours. The second graph shows mean Ethinyl Estradiol concentrations (pg/mL) over the same time frame and conditions.*

FDA Label Image

Image (Sronyx 03)

A forest plot showing effect estimates (OR/RR) with confidence intervals for various contraceptive studies from 2002 to 2017, including the NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis represents the effect estimate values ranging from -1.5 to 2.0.*

FDA Label Image

Image (Sronyx 04)

SRONYX kit label showing a 4-week tablet schedule for Levonorgestrel and Ethinyl Estradiol tablets USP, 0.1 mg/0.02 mg. The label features a weekly grid from Sunday to Saturday with arrows guiding daily tablet intake and indicates that tablets in week 4 are inactive. The label also reminds monthly self-breast examination and includes the product NDC 51862-545-01.*

FDA Label Image

Principal Display Panel (Kit Carton)

SRONYX Kit packaging insert showing a 28-day calendar grid for tracking daily tablets of Levonorgestrel and Ethinyl Estradiol. The layout includes four rows labeled 1 to 4 for the weekly dosage schedule, with arrows guiding tablet intake from Sunday to Saturday and a note indicating monthly self-breast exam. The fourth week tablets are marked as inactive.*

FDA Label Image

Sronyx 06

SRONYX kit containing Levonorgestrel and Ethinyl Estradiol tablets USP for a 28-day regimen. The label indicates six blister cards with 28 tablets each. Manufacturer and distributor are Mayne Pharma Inc. and Patheon Inc. The packaging highlights dosage and storage instructions along with a barcode and NDC 51862-545-06.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.